A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin. Issue 8 (5th May 2020)

• Record Type: Journal Article
• Authors: Meconi, Federico; Provenzano, Ida; Nasso, Daniela; Mariotti, Benedetta; Pupo, Livio; Secchi, Roberto; Cerretti, Raffaella; Lucia, Anemona; Arcese, William; Cantonetti, Maria
• Is Part Of: Clinical case reports. Volume 8:Issue 8(2020)
• Page Start: 1353
• Page End: 1356
• Publication Date: 2020-05-05
• Subjects: brentuximab vedotin -- Hodgkin lymphoma -- non‐Hodgkin T‐cell lymphoma; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2898
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL. Abstract : Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL.